Exchange: NASDAQ·Updated 07:30 PM EST

IVF News

News
all
press releases
Nike, Meta Platforms, INVO Fertility, EyePoint Pharmaceuticals, and Micron: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices ended lower on Monday, with the Dow Jones Industrial Average falling 0.51% to 53,459.78read more...
Benzinga
Nike, Meta Platforms, INVO Fertility, EyePoint Pharmaceuticals, and Micron: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices ended lower on Monday, with the Dow Jones Industrial Average falling 0.51% to 53,459.78read more...
Benzinga
More News
Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out today.read more...
Benzinga
Shares of INVO Fertility are surging Monday after it reported Q2 results that outperformed Wall Street expectations on bottom-line earnings.read more...
Benzinga
Here are today’s catalysts that are changing the narrative. $NTHI, $IPST, $OABI, $LLY, $HIVE, and $IVF
24-7 Market News
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-market session. The company's market cap stands at $1.7 million. GlucoTrack (NASDAQ:GCTK) shares moved upwards byread more...
Benzinga
HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's new agreement. Other gainers include IP Strategy Holdings, INVO Fertility, My Size, Trugolf Holdings, Expion360, Skye Bioscience, Julong Holding, FIEE Inc, and Keel Infrastructure. Losers include...
Benzinga
INVO Fertility (IVF) shares pull back after doubling on news of a Birmingham clinic acquisition and resolving its Nasdaq compliance issue.read more...
Benzinga
INVO Fertility shares are surging Friday afternoon after key operational and regulatory milestones disclosed in SEC Form 8-K filing.read more...
Benzinga
Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regular session. The market value of their outstanding shares is at $2.2 million. The company's, Q1 earnings came out 4read more...
Benzinga
INVO Fertility (NASDAQ:IVF) reported its first-quarter 2026 financial results, this week, which highlighted revenue growth, continued expansion of its fertility clinic network, and significant improvements to its capital structure. The company reported first-quarter revenue of approximately $2.0 million, representing a 23% increase from the same period a year earlier. Management attributed the growth to both organic expansion across existing clinics and the contribution from its February 2026 acquisition of Family Beginnings, reinforcing the company's dual strategy of growing existing operations while acquiring established fertility practices.
24-7 Market News

Advertisement|Remove ads.